CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 10, 2022 · earnings

IMRX earnings: a positive outcome, +14.0%

On May 10, 2022, Immuneering Corp reached its earnings. The result was a positive outcome, and the stock moved +14.0% in the window around the event. It had already run -30.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$4.29
1d before
$4.89
Event day
$4.42
1d after
$5.03
5d after

Pre-catalyst setup

-30.6%
30-day run-up
9507%
30-day volatility
1.5×
volume spike